JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Inicio・Lista de Acciones・Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc

Cerrado

SectorSanidad

28.74 2.2

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

28.54

Máximo

28.8

Métricas clave
By Trading Economics
Ingresos	-85K 53M
Ventas	4.2M 153M
P/B Media del Sector	17.423 67.147
BPA	0.68
Margen de beneficios	34.53
Empleados	182
EBITDA	612K 81M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+20.04% upside

Dividendos
By Dow Jones
Próximas Ganancias	11 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	611M 3.6B
Apertura anterior	26.54
Cierre anterior	28.74

Noticias sobre sentimiento de mercado

By Acuity

50%

160 / 347 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

N/A / 24.28 Soporte y Resistencia

Catalyst Pharmaceuticals Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

1 may 2026, 21:36 UTC

Adquisiciones, fusiones, absorciones

FTC Requires 365 Retail Markets to Divest Micromarket Kiosk Business to Clear Acquisition of Cantaloupe

1 may 2026, 20:40 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms Acquires Humanoid Robot Startup Assured Robot Intelligence

1 may 2026, 18:37 UTC

Principales Movimientos del Mercado

Senseonic Shares Slide on Underwritten Offering Price

1 may 2026, 16:46 UTC

Principales Movimientos del Mercado

Stellantis, Ferrari Fall on Trump Plan to Increase Tariff on European Cars, Trucks

2 may 2026, 19:57 UTC

Adquisiciones, fusiones, absorciones

Berkshire CEO Greg Abel Takes the Stage, Making a Case for the Post-Buffett Era -- 3rd Update

2 may 2026, 15:24 UTC

Ganancias

Berkshire CEO Greg Abel Takes the Stage, Talks Through Quarterly Results -- Update

2 may 2026, 12:46 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Berkshire Profits More Than Double on Gains in Insurance, Railroad, Energy Businesses -- WSJ

2 may 2026, 08:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

1 may 2026, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

1 may 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

1 may 2026, 20:42 UTC

Ganancias

Western Digital Beats Earnings Estimates. The Stock Is Falling Anyway. -- Barrons.com

1 may 2026, 19:33 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

1 may 2026, 19:33 UTC

Charlas de Mercado

Change in Fed Leadership May Hamper Crypto Rebound -- Market Talk

1 may 2026, 19:18 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Rises for Second Consecutive Week Amid Middle East Standoff -- Market Talk

1 may 2026, 19:13 UTC

Charlas de Mercado

Natural Gas Rises as Markets Wait for Warmer Temperatures -- Market Talk

1 may 2026, 18:36 UTC

Ganancias

3 Takeaways From Apple Earnings. The Stock Is Surging. -- Barrons.com

1 may 2026, 18:35 UTC

Ganancias

Moderna's Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway. -- Barrons.com

1 may 2026, 18:28 UTC

Ganancias

These Stocks Are Today's Movers: Apple, Sandisk, Roblox, Intel, Ferrari, Atlassian, Western Digital, Clorox, Paramount Skydance, and More -- Barrons.com

1 may 2026, 18:27 UTC

Charlas de Mercado

Gold and Silver Higher for the Day, Lower For The Week -- Market Talk

1 may 2026, 18:14 UTC

Adquisiciones, fusiones, absorciones

Barclays Completes Acquisition of Best Egg

1 may 2026, 18:04 UTC

Ganancias

The First $6 Trillion Company May Not Be Nvidia -- Barrons.com

1 may 2026, 17:43 UTC

Charlas de Mercado

Home Sales in San Francisco Jump 22.2% in March -- Market Talk

1 may 2026, 17:37 UTC

Charlas de Mercado

Crypto 'Fear and Greed Index' Returns to Neutral Reading After Brief Dip -- Market Talk

1 may 2026, 17:30 UTC

Charlas de Mercado

Ganancias

Apple's 2Q Print, 3Q Guide Set Up Stock to Outperform -- Market Talk

1 may 2026, 17:28 UTC

Charlas de Mercado

Ganancias

Apple's Shift From Net Cash Neutral Goal Seen as Cryptic Signal -- Market Talk

1 may 2026, 17:21 UTC

Charlas de Mercado

Ganancias

Apple Seen Absorbing Higher Memory Costs -- Market Talk

1 may 2026, 17:19 UTC

Charlas de Mercado

Noticias de Eventos Importantes

U.S. Oil Rig Count Rises by 1 to 408 -- Market Talk

1 may 2026, 16:38 UTC

Charlas de Mercado

Institutional Markets Begin to Trade on Event Contracts -- Market Talk

1 may 2026, 16:23 UTC

Adquisiciones, fusiones, absorciones

Paramount Skydance Gets a Double Upgrade. It's the Warner Bros. Deal. -- Barrons.com

1 may 2026, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Catalyst Pharmaceuticals Inc previsión

Precio Objetivo

By TipRanks

20.04% repunte

Estimación a 12 Meses

Media 34.5 USD 20.04%

Máximo 35 USD

Mínimo 33 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Catalyst Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Catalyst Pharmaceuticals Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

N/A / 24.28Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Sentimiento

By Acuity

160 / 347 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.